Hepakind 150 Tablet contains Ursodeoxycholic Acid 150 mg, a hydrophilic bile acid used primarily in the treatment of various hepatobiliary disorders. It is indicated for the dissolution of cholesterol gallstones in patients with a functioning gallbladder and radiolucent stones, as well as for the management of primary biliary cholangitis (PBC), a chronic autoimmune liver disease. Ursodeoxycholic Acid works by reducing the cholesterol content of bile, thereby decreasing cholesterol saturation and promoting the gradual dissolution of cholesterol-rich gallstones. Additionally, it exerts cytoprotective effects on hepatocytes by stabilizing cell membranes and reducing the toxic effects of endogenous bile acids. Hepakind 150 is also utilized to improve liver function tests and delay disease progression in cholestatic liver conditions. The medication is generally well-tolerated, with adverse effects being mild and infrequent, including gastrointestinal disturbances such as diarrhea and nausea. It is contraindicated in patients with complete biliary obstruction and those with hypersensitivity to Ursodeoxycholic Acid. Dosage and duration of therapy should be individualized based on clinical response and diagnostic findings, under the supervision of a healthcare professional. Regular monitoring of liver function tests is recommended during treatment to assess efficacy and safety.